A Centrally Acting Antihypertensive, Clonidine, Sedates Patients Presenting With Acute Respiratory Distress Syndrome Evoked by Severe Acute Respiratory Syndrome-Coronavirus 2

Crit Care Med. 2020 Oct;48(10):e991-e993. doi: 10.1097/CCM.0000000000004503.

Authors

Fabrice Petitjeans¹, Jean-Yves Martinez, Marc Danguy des Déserts, Sandrine Leroy, Luc Quintin, Jacques Escarment

Affiliation

¹ Critical Care, Hôpital d'Instruction des Armées Desgenettes, Lyon, France; and Élément Militaire de Réanimation, Centre Hospitalier, Mulhouse, and Epismart, Paris, France.

No abstract available

Publication types

Review

MeSH terms

Adult
Aged
Antihypertensive Agents / administration & dosage*
COVID-19
Clonidine / administration & dosage*
Conscious Sedation / methods
Coronavirus Infections / epidemiology*
Critical Care / methods
Critical Illness / mortality
Critical Illness / therapy
Female
France
Hospital Mortality / trends
Humans
Intensive Care Units / statistics & numerical data*
Length of Stay
Male
Middle Aged
Pandemics
Pneumonia, Viral / epidemiology*
Prognosis
Respiratory Distress Syndrome / diagnosis
Respiratory Distress Syndrome / drug therapy*
Risk Assessment
Severe Acute Respiratory Syndrome / drug therapy*
Severe Acute Respiratory Syndrome / etiology
Treatment Outcome

Substances

Antihypertensive Agents
Clonidine